PAM
HAE icon

Panagora Asset Management’s Haemonetics HAE Stock Holding History

Panagora Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Buy
+21,362
New +$1.39M ﹤0.01% 671
2024
Q4 		– Sell
-33,805
Closed -$2.72M – 1190
2024
Q3 		$2.72M Buy
33,805
+248
+0.7% +$20K 0.01% 478
2024
Q2 		$2.78M Sell
33,557
-2,032
-6% -$179K 0.01% 436
2024
Q1 		$3.04M Sell
35,589
-6,176
-15% -$485K 0.02% 449
2023
Q4 		$3.57M Sell
41,765
-1,022
-2% -$88.4K 0.02% 398
2023
Q3 		$3.83M Buy
+42,787
New +$3.82M 0.02% 361
2023
Q2 		– Sell
-59,116
Closed -$4.89M – 1347
2023
Q1 		$4.89M Sell
59,116
-139,717
-70% -$11.3M 0.03% 372
2022
Q4 		$15.6M Buy
198,833
+1,933
+1% +$155K 0.1% 203
2022
Q3 		$14.6M Sell
196,900
-18,353
-9% -$1.32M 0.1% 195
2022
Q2 		$14M Sell
215,253
-20,385
-9% -$1.21M 0.09% 213
2022
Q1 		$14.9M Buy
235,638
+12,291
+6% +$668K 0.08% 218
2021
Q4 		$11.8M Sell
223,347
-1,446
-0.6% -$88.1K 0.06% 271
2021
Q3 		$15.9M Sell
224,793
-3,144
-1% -$198K 0.08% 222
2021
Q2 		$15.2M Buy
227,937
+226,874
+21,343% +$16.1M 0.08% 224
2021
Q1 		$118K Sell
1,063
-3,495
-77% -$432K ﹤0.01% 1917
2020
Q4 		$541K Sell
4,558
-3,944
-46% -$425K ﹤0.01% 1193
2020
Q3 		$742K Sell
8,502
-12,500
-60% -$1.09M ﹤0.01% 1005
2020
Q2 		$1.88M Sell
21,002
-49,308
-70% -$4.98M 0.01% 697
2020
Q1 		$7.01M Buy
70,310
+5,699
+9% +$618K 0.05% 283
2019
Q4 		$7.42M Sell
64,611
-22,846
-26% -$2.76M 0.03% 388
2019
Q3 		$11M Sell
87,457
-183,836
-68% -$23.3M 0.05% 308
2019
Q2 		$32.6M Sell
271,293
-248,616
-48% -$24.5M 0.15% 157
2019
Q1 		$45.5M Sell
519,909
-123,594
-19% -$11.2M 0.2% 119
2018
Q4 		$64.4M Sell
643,503
-59,323
-8% -$6.23M 0.3% 80
2018
Q3 		$80.5M Sell
702,826
-31,846
-4% -$3.3M 0.3% 80
2018
Q2 		$65.9M Sell
734,672
-58,318
-7% -$4.92M 0.26% 99
2018
Q1 		$58M Buy
792,990
+8,097
+1% +$556K 0.23% 104
2017
Q4 		$45.6M Buy
784,893
+84,027
+12% +$4.42M 0.17% 132
2017
Q3 		$31.4M Sell
700,866
-43,553
-6% -$1.81M 0.12% 181
2017
Q2 		$29.4M Sell
744,419
-106,060
-12% -$4.36M 0.12% 189
2017
Q1 		$34.5M Buy
850,479
+271,305
+47% +$10.6M 0.14% 161
2016
Q4 		$23.3M Buy
579,174
+83,972
+17% +$3.17M 0.11% 194
2016
Q3 		$17.9M Buy
495,202
+348,391
+237% +$12M 0.09% 234
2016
Q2 		$4.26M Buy
146,811
+14,259
+11% +$431K 0.02% 603
2016
Q1 		$4.64M Sell
132,552
-9,223
-7% -$298K 0.02% 599
2015
Q4 		$4.57M Hold
141,775
– – 0.02% 575
2015
Q3 		$4.58M Buy
141,775
+2,363
+2% +$88.9K 0.02% 528
2015
Q2 		$5.77M Sell
139,412
-10,253
-7% -$432K 0.03% 479
2015
Q1 		$6.72M Sell
149,665
-54,582
-27% -$2.28M 0.03% 419
2014
Q4 		$7.64M Buy
204,247
+102,240
+100% +$3.75M 0.04% 373
2014
Q3 		$3.56M Sell
102,007
-78,781
-44% -$2.81M 0.02% 585
2014
Q2 		$6.38M Buy
180,788
+72,624
+67% +$2.43M 0.03% 449
2014
Q1 		$3.52M Buy
+108,164
New +$4.13M 0.02% 661

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Panagora Asset Management's HAE Position: Q1 2026 in Review

Panagora Asset Management opened a new position in Haemonetics (HAE) in Q1 2026: 21,362 shares worth $1.2M. The stake represents ﹤0.01% of the portfolio and ranks #671 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in HAE as recently as Q3 2024.

Panagora Asset Management first reported a position in HAE in Q1 2014 and has held it in 43 quarters since. The position peaked at $80.5M in Q3 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Panagora Asset Management held 21,362 shares of Haemonetics worth $1.2M as of Q1 2026.
  • Haemonetics was a new Panagora Asset Management position in Q1 2026.
  • Haemonetics made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #671 holding.
  • Panagora Asset Management first reported a position in Haemonetics in Q1 2014 and has held it in 43 quarters since.
  • Panagora Asset Management's Haemonetics position peaked at $80.5M in Q3 2018.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.